Related Experiment Videos

Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone

Insights

Chlorthalidone, a diuretic, significantly increased low-density lipoprotein cholesterol (LDL-C) in men. These changes in lipid profiles occurred without affecting other metabolic factors.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Essential hypertension management often involves diuretics.
  • Lipoprotein alterations are a concern with antihypertensive therapies.

Purpose of the Study:

  • To evaluate the impact of chlorthalidone on serum lipoproteins.
  • To assess changes in LDL-C, HDL-C, and apolipoproteins.

Main Methods:

  • 37 subjects (hypertensive men, normal men, hypertensive women) received 100 mg/day chlorthalidone for 6 weeks.
  • Serum lipoproteins and apolipoproteins were measured.
  • Correlations with plasma volume, electrolytes, glucose, insulin, blood pressure, and weight were analyzed.

Main Results:

  • Chlorthalidone significantly increased LDL-C by 20% in hypertensive and normal men.
  • A trend for increased LDL-C was observed in postmenopausal women.
  • High-density lipoprotein cholesterol decreased slightly in hypertensive men; apolipoproteins remained unchanged.

Conclusions:

  • Short-term chlorthalidone therapy may elevate LDL-C in men across different blood pressure ranges.
  • Lipoprotein alterations were independent of plasma volume and metabolic changes.
  • Further research is needed to understand long-term cardiovascular implications.

Related Concept Videos